RNA therapeutics

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Novartis to acquire Avidity Biosciences

Lucid Diligence Brief: Novartis to acquire Avidity Biosciences Professional…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Bristol Myers Squibb's acquisition of Orbital Therapeutics

Lucid Diligence Brief: Bristol Myers Squibb's acquisition of Orbital…

by Timos Papagatsias

Rare Disease news

Rare Diseases Weekly News - August 28th 2025

🧬 This Week in Rare Diseases: FDA Approvals, Gene Therapies, Global Screening…

by LucidQuest

Neuroscience

Neuroscience Weekly News - July 16th 2025

🧠 This Week in Neuroscience: MS Guidelines, ALS Gene Therapy, Dementia Risks,…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.